Insider Trading History of Sommadossi Jean-pierre

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Sommadossi Jean-pierre since 2006. This trader's CIK number is 1296995. At the time of last reporting, Sommadossi Jean-pierre was the President, CEO, and Chairman of Atea Pharmaceuticals, Inc.. (stock ticker symbol AVIR). Also see all insider trading activities at Atea Pharmaceuticals, Inc..

Note that in the past Sommadossi Jean-Pierre also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Idenix Pharmaceuticals Inc (IDIX) by Sommadossi Jean-pierre

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 IDIX 10,000 $91,300 0 $0 0 $0

Yearly summary of insider trading at Atea Pharmaceuticals, Inc. (AVIR) by Sommadossi Jean-pierre

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 AVIR 0 $0 0 $0 173,467 $0
2024 AVIR 0 $0 115,885 $457,014 173,467 $0


Insider trading activities at 2 companies by Sommadossi Jean-pierre:

1. Idenix Pharmaceuticals Inc (IDIX)

2. Atea Pharmaceuticals, Inc. (AVIR)

Table 1. Insider trading of Idenix Pharmaceuticals Inc (IDIX) by Sommadossi Jean-pierre

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-05-09 IDIX Buy 10,000 9.13 91,300

Table 2. Insider trading of Atea Pharmaceuticals, Inc. (AVIR) by Sommadossi Jean-pierre

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-01-31 AVIR Option Ex 173,467 .00 0
2024-09-19 AVIR Sale 1,841 4.00 7,367
2024-09-18 AVIR Sale 22,187 4.03 89,480
2024-09-17 AVIR Sale 33,941 4.05 137,325
2024-06-05 AVIR Sale 1,006 4.00 4,024
2024-02-01 AVIR Sale 56,910 3.85 218,818
2024-01-31 AVIR Option Ex 173,467 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sommadossi Jean-pierre (President, CEO, and Chairman of Atea Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.